Axium PrimeTM FC-3-8-3DRecalls & reported problems
Micro Therapeutics, Inc. · COIL FC-3-8-3D V03 · Class 2 · Implant
All models of Axium PrimeTM (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00847536034068), received between Aug 16, 2021 and Mar 1, 2023 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Material Deformation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Material Deformation2
- Detachment of Device or Device Component1
- Difficult or Delayed Positioning1
- Separation Failure1
- Stretched1
- Unintended Movement1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Obstruction/Occlusion1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 1, 2023Material Deformation; Material Deformation
MEDTRONIC RECEIVED A REPORT THAT THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF AN ANEURYSM. IT WAS REPORTED THAT THE AXIUM COIL'S WIRE WAS BROKEN SO THE DOCTOR COULDN'T SELECT THE COIL IN LESION. THE REPORTED DEVICE AND ANY ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. NEW INFORMATION WAS RECEIVED. THE PUSHWIRE WAS THE PART OF THE COIL WITH THE DAMAGE. THERE WERE NO ISSUES THAT RESULTED IN THE DAMAGE THAT WAS FOUND.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16463694 ↗MalfunctionFeb 23, 2023Material Deformation; Material Deformation
MEDTRONIC RECEIVED A REPORT THAT THE AXIUM COIL'S WIRE WAS BROKEN SO THE DOCTOR FAILED TO SELECT ON TARGET LESION. THE REPORTED DEVICE AND ANY ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF AN ANEURYSM. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS UNKNOWN AND VESSEL TORTUOSITY WAS UNKNOWN. ADDITIONAL INFORMATION WAS RECEIVED THAT ACTIONS TAKEN TO RESOLVE THE PUSHWIRE DAMAGE WAS THEY CHANGED TO A NEW DEVICE WHEN THE PROBLEM OCCURRED. IT WAS CLARIFIED THAT "THE DOCTOR FAILED TO SELECT ON TARGET LESION" THAT THE DOCTOR COULDN'T CONTROL THE COIL BECAUSE OF THE PUSHWIRE. THERE WERE NO ISSUES THAT RESULTED IN THE DAMAGE THAT WAS FOUND.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16432196 ↗MalfunctionDec 1, 2022Separation Failure; Separation Failure
ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE COIL ADVANCED AND FORMED AS NORMAL. PUSHWIRE DAMAGE WAS OBSERVED AFTER REMOVAL FROM THE PATIENT ONLY FROM TRYING TO MANUALLY DETACH.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15894231 ↗MalfunctionAug 16, 2021Difficult or Delayed Positioning; Stretched; Detachment of Device or Device Component; Unintended Movement; Difficult or Delayed Positioning; Stretched; Detachment of Device or Device Component; Unintended Movement
MEDTRONIC RECEIVED INFORMATION REGARDING AN AXIUM FRAMING COIL THAT HAD DIFFICULTY WITH POSITIONING AND BLOCKED THE PARENT VESSEL AND THEN DETACHED PREMATURELY. THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE TO TREAT A RUPTURED AMORPHOUS ANEURYSM OF THE RIGHT ANTERIOR COMMUNICATING ARTERY. THE ANEURYSM MAX DIAMETER WAS 4.02MM AND THE NECK DIAMETER WAS 2.89MM. BLOOD FLOW WAS NORMAL. VESSEL TORTUOSITY WAS MINIMAL. IT WAS REPORTED THAT THE MICROCATHETER WAS IN PLACE AND THE AXIUM FRAMING COIL WAS SELECTED TO FORM THE HOOP. DURING HOOP FORMATION, THE COIL WAS ADJUSTED SLIGHTLY AND HOOP FORMATION WAS CONSIDERED COMPLETE. HOWEVER, ANGIOGRAPHY REVEALED BLOOD FLOW OF ONE OF THE A2 VESSELS WAS BLOCKED SO ADJUSTMENT OF THE COIL WAS ATTEMPTED AND THE COIL WAS FOUND STRETCHED AND DETACHED. IT WAS NOTED THAT THERE WAS NO FRICTION OR DIFFICULTY DURING DELIVERY OF THE COIL. THERE WAS NO DAMAGE TO THE PUSHWIRE. THE PHYSICIAN DID NOT ATTEMPT TO DETACH THE COIL. CONTINUOUS CATHETER FLUSH WAS ADMINISTERED DURING THE PROCEDURE. THE AXIUM FRAMING COIL AND ALL ACCESSORY DEVICES WERE PREPARED PER THE INSTRUCTIONS FOR USE (IFU). THE COIL EMBOLIZATION PROCEDURE CONTINUED. THOUGH THERE WAS AFFECTE
Patient problems: Obstruction/Occlusion
MAUDE report 12324891 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page